Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Arrow Exploration brings new Colombian oil well on stream ahead of schedule and under budget - 2Figure out How to Pick the Right Dental specialist for Your Dental Inserts
- 3Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in small trial
- 4Marvel's X-Men are joining the battle in 'Avengers: Doomsday': Watch the teaser
- 5Putin, Netanyahu discuss Middle East in phone call, Kremlin says
- Artemis 2 moon rocket gets 'America 250' paint job | Space photo of the day for Dec. 23, 2025
- How a cocktail of rogue storms and climate chaos unleashed deadly flooding across Asia
- WHO issues guidance on GLP-1 drugs for obesity
- 6 Famous Urban communities for Shopping on the planet
- South Korea president says Iran war shows the need to ditch ‘extremely risky’ fossil fuels
- Chief of Staff Zamir warns IDF will collapse due to lack of manpower, raises 'ten red flags'
- 6 Modest and Strong Tire Brands
- 2025 among world's three hottest years on record, WMO says
- SF Chinatown's historic Empress of China building being revived into cultural campus
